Vault-13

TCG Crossover Management, LLC

PALO ALTO, CA · CIK 1839948 · 13F filing filed 2024-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$959.5m reported value -24.1% vs Q1 2024
32positions
64.7%in top 10
2 new 6 added 4 reduced 3 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 3,670,206 $115.9m12.08% 12.08% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.6m, Q2 2024 3.7m +100.0k +100,000 2.8%
2 DYNE THERAPEUTICS INC COM DYN DYN 2,650,150 $93.5m9.75% 9.75% UnchangedShares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 2.7m, Q2 2024 2.7m
3 ABIVAX SA SPONSORED ADS ABVX ABVX 6,056,596 $80.1m8.34% 8.34% AddedShares held: Q3 2023 0, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 6.1m +5.0m +4,956,596 450.6%
4 SILENCE THERAPEUTICS PLC ADS SLN SLN 3,295,350 $62.6m6.53% 6.53% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.1m, Q1 2024 3.3m, Q2 2024 3.3m
5 COGENT BIOSCIENCES INC COM COGT COGT 6,964,375 $58.7m6.12% 6.12% AddedShares held: Q3 2023 5.6m, Q4 2023 5.6m, Q1 2024 6.2m, Q2 2024 7.0m +750.0k +750,000 12.1%
6 SAVARA INC COM SVRA SVRA 12,362,205 $49.8m5.19% 5.19% AddedShares held: Q3 2023 10.0m, Q4 2023 10.0m, Q1 2024 10.0m, Q2 2024 12.4m +2.4m +2,362,205 23.6%
7 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 149,283 $41.8m4.36% 4.36% UnchangedShares held: Q3 2023 179.9k, Q4 2023 179.9k, Q1 2024 149.3k, Q2 2024 149.3k
8 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,272,728 $40.9m4.27% 4.27% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.3m, Q2 2024 2.3m
9 KEROS THERAPEUTICS INC COM KROS KROS 879,344 $40.2m4.19% 4.19% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 879.3k, Q2 2024 879.3k
10 MINERALYS THERAPEUTICS INC COM MLYS MLYS 3,185,185 $37.3m3.88% 3.88% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 3.2m, Q2 2024 3.2m
11 OCULAR THERAPEUTIX INC COM OCUL OCUL 5,319,148 $36.4m3.79% 3.79% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.3m, Q2 2024 5.3m
12 TYRA BIOSCIENCES INC COM TYRA TYRA 1,989,103 $31.8m3.31% 3.31% UnchangedShares held: Q3 2023 2.0m, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 2.0m
13 KURA ONCOLOGY INC COM KURA KURA 1,423,642 $29.3m3.06% 3.06% UnchangedShares held: Q3 2023 1.4m, Q4 2023 1.4m, Q1 2024 1.4m, Q2 2024 1.4m
14 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 694,547 $27.3m2.84% 2.84% ReducedShares held: Q3 2023 1.5m, Q4 2023 2.1m, Q1 2024 1.6m, Q2 2024 694.5k -903.9k -903,874 -56.5%
15 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 2,890,816 $26.1m2.72% 2.72% AddedShares held: Q3 2023 2.0m, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 2.9m +850.0k +850,000 41.6%
16 ASTRIA THERAPEUTICS INC COM CATB CATB 2,761,861 $25.1m2.62% 2.62% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.3m, Q2 2024 2.8m -2.5m -2,517,067 -47.7%
17 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 3,858,000 $23.3m2.43% 2.43% UnchangedShares held: Q3 2023 3.9m, Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 3.9m
18 SOLENO THERAPEUTICS INC COM NEW SLNO SLNO 550,000 $22.4m2.34% 2.34% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 550.0k, Q2 2024 550.0k
19 DISC MEDICINE INC COM IRON IRON 486,957 $21.9m2.29% 2.29% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 487.0k
20 TOURMALINE BIO INC COM TRML TRML 1,477,593 $19.0m1.98% 1.98% UnchangedShares held: Q3 2023 0, Q4 2023 1.0m, Q1 2024 1.5m, Q2 2024 1.5m
21 TARSUS PHARMACEUTICALS INC COM TARS TARS 556,317 $15.1m1.58% 1.58% ReducedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 793.8k, Q2 2024 556.3k -237.5k -237,512 -29.9%
22 ADVERUM BIOTECHNOLOGIES INC COM COM 2,008,340 $13.8m1.44% 1.44% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.0m, Q2 2024 2.0m
23 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 2,676,580 $9.3m0.97% 0.97% UnchangedShares held: Q3 2023 0, Q4 2023 2.7m, Q1 2024 2.7m, Q2 2024 2.7m
24 ENTRADA THERAPEUTICS INC COM TRDA TRDA 584,955 $8.3m0.87% 0.87% UnchangedShares held: Q3 2023 585.0k, Q4 2023 585.0k, Q1 2024 585.0k, Q2 2024 585.0k
25 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 922,335 $8.0m0.84% 0.84% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 922.3k
26 C4 THERAPEUTICS INC COM STK CCCC CCCC 1,276,574 $5.9m0.61% 0.61% UnchangedShares held: Q3 2023 1.3m, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.3m
27 NEKTAR THERAPEUTICS COM COM 4,000,000 $5.0m0.52% 0.52% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 4.0m, Q2 2024 4.0m
28 AEROVATE THERAPEUTICS INC COM COM 2,240,809 $3.7m0.39% 0.39% AddedShares held: Q3 2023 2.2m, Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m +39.5k +39,535 1.8%
29 AN2 THERAPEUTICS INC COM ANTX ANTX 1,555,118 $3.3m0.35% 0.35% UnchangedShares held: Q3 2023 2.7m, Q4 2023 2.7m, Q1 2024 1.6m, Q2 2024 1.6m
30 KODIAK SCIENCES INC COM KOD KOD 899,999 $2.1m0.22% 0.22% UnchangedShares held: Q3 2023 0, Q4 2023 267.9k, Q1 2024 900.0k, Q2 2024 900.0k
31 VENTYX BIOSCIENCES INC COM VTYX VTYX 316,195 $730.4k0.08% 0.08% ReducedShares held: Q3 2023 815.7k, Q4 2023 815.7k, Q1 2024 815.7k, Q2 2024 316.2k -499.5k -499,529 -61.2%
32 CABALETTA BIO INC COM CABA CABA 86,795 $649.2k0.07% 0.07% UnchangedShares held: Q3 2023 486.8k, Q4 2023 486.8k, Q1 2024 86.8k, Q2 2024 86.8k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
INHIBRX INC INBX INBX 1,750,387 $61.2m1.8m shares
GERON CORP GERN GERN 17,391,639 $57.4m17.4m shares
KALVISTA PHARMACEUTICALS INC KALV KALV 1,163,356 $13.8m1.2m shares